Global Vaginal Anti Infectives Production, Demand and Key Producers, 2022-2028
Vaginal anti-infectives are the type of agents that are used for the killing or supressing the infection of vagina caused by numerous bacteria, virus, fungi or micro-organism. These bacteria and others invade the host by means of its replication or releasing several toxins into the host. 'Yeast' infections, tyrichomoniasis vaginitis, bacterial vaginosis, chlamydia vaginitis, and viral vaginitis are the major forms of vaginitis. About one third women all over the world experience indications of vaginitis at some point in their lifetime. Women are highly prone to vaginitis during the reproductive age; a change in the balance of bacteria and yeast present in vagina can lead to vaginitis.
This report studies the global Vaginal Anti Infectives production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Vaginal Anti Infectives, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vaginal Anti Infectives that contribute to its increasing demand across many markets.
The global Vaginal Anti Infectives market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Vaginal Anti Infectives total production and demand, 2017-2028, (K Units)
Global Vaginal Anti Infectives total production value, 2017-2028, (USD Million)
Global Vaginal Anti Infectives production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Vaginal Anti Infectives consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Vaginal Anti Infectives domestic production, consumption, key domestic manufacturers and share
Global Vaginal Anti Infectives production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Vaginal Anti Infectives production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Vaginal Anti Infectives production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Vaginal Anti Infectives market based on the following parameters – headquarters, production locations, products portfolio, Vaginal Anti Infectives revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vaginal Anti Infectives market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Vaginal Anti Infectives Market, By Region:
1. How big is the global Vaginal Anti Infectives market?
2. What is the demand of the global Vaginal Anti Infectives market?
3. What is the year over year growth of the global Vaginal Anti Infectives market?
4. What is the production and production value of the global Vaginal Anti Infectives market?
5. Who are the key producers in the global Vaginal Anti Infectives market?
6. What are the growth factors driving the market demand?
This report studies the global Vaginal Anti Infectives production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Vaginal Anti Infectives, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vaginal Anti Infectives that contribute to its increasing demand across many markets.
The global Vaginal Anti Infectives market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Vaginal Anti Infectives total production and demand, 2017-2028, (K Units)
Global Vaginal Anti Infectives total production value, 2017-2028, (USD Million)
Global Vaginal Anti Infectives production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Vaginal Anti Infectives consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Vaginal Anti Infectives domestic production, consumption, key domestic manufacturers and share
Global Vaginal Anti Infectives production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Vaginal Anti Infectives production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Vaginal Anti Infectives production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Vaginal Anti Infectives market based on the following parameters – headquarters, production locations, products portfolio, Vaginal Anti Infectives revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vaginal Anti Infectives market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Vaginal Anti Infectives Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Oral
- Ointment
- Bacterial Vaginitis
- Trichomonal Vaginitis
- Candida Vaginitis
- Pfizer Inc
- Mylan N.V
- Novartis AG
- Hikma Pharmaceuticals plc
- Aurobindo Pharma
- AbbVie Inc
- Melinta Therapeutics, Inc
- Bristol-Myers Squibb Company
- GSK plc
- Bayer AG
- Lupin
- Perrigo Company plc
1. How big is the global Vaginal Anti Infectives market?
2. What is the demand of the global Vaginal Anti Infectives market?
3. What is the year over year growth of the global Vaginal Anti Infectives market?
4. What is the production and production value of the global Vaginal Anti Infectives market?
5. Who are the key producers in the global Vaginal Anti Infectives market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Vaginal Anti Infectives Introduction
1.2 World Vaginal Anti Infectives Supply & Forecast
1.2.1 World Vaginal Anti Infectives Production Value (2017 & 2021 & 2028)
1.2.2 World Vaginal Anti Infectives Production (2017-2028)
1.2.3 World Vaginal Anti Infectives Pricing Trends (2017-2028)
1.3 World Vaginal Anti Infectives Production by Region
1.3.1 World Vaginal Anti Infectives Production Value by Region (2017-2028)
1.3.2 World Vaginal Anti Infectives Production by Region (2017-2028)
1.3.3 World Vaginal Anti Infectives Average Price by Region (2017-2028)
1.3.4 North America Vaginal Anti Infectives Production (2017-2028)
1.3.5 Europe Vaginal Anti Infectives Production (2017-2028)
1.3.6 China Vaginal Anti Infectives Production (2017-2028)
1.3.7 Japan Vaginal Anti Infectives Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Vaginal Anti Infectives Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Vaginal Anti Infectives Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Vaginal Anti Infectives Demand (2017-2028)
2.2 World Vaginal Anti Infectives Consumption by Region
2.2.1 World Vaginal Anti Infectives Consumption by Region (2017-2022)
2.2.2 World Vaginal Anti Infectives Consumption Forecast by Region (2023-2028)
2.3 United States Vaginal Anti Infectives Consumption (2017-2028)
2.4 China Vaginal Anti Infectives Consumption (2017-2028)
2.5 Europe Vaginal Anti Infectives Consumption (2017-2028)
2.6 Japan Vaginal Anti Infectives Consumption (2017-2028)
2.7 South Korea Vaginal Anti Infectives Consumption (2017-2028)
2.8 ASEAN Vaginal Anti Infectives Consumption (2017-2028)
2.9 India Vaginal Anti Infectives Consumption (2017-2028)
3 WORLD VAGINAL ANTI INFECTIVES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Vaginal Anti Infectives Production Value by Manufacturer (2017-2022)
3.2 World Vaginal Anti Infectives Production by Manufacturer (2017-2022)
3.3 World Vaginal Anti Infectives Average Price by Manufacturer (2017-2022)
3.4 Vaginal Anti Infectives Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Vaginal Anti Infectives Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Vaginal Anti Infectives in 2021
3.5.3 Global Concentration Ratios (CR8) for Vaginal Anti Infectives in 2021
3.6 Vaginal Anti Infectives Market: Overall Company Footprint Analysis
3.6.1 Vaginal Anti Infectives Market: Region Footprint
3.6.2 Vaginal Anti Infectives Market: Company Product Type Footprint
3.6.3 Vaginal Anti Infectives Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Vaginal Anti Infectives Production Value Comparison
4.1.1 United States VS China: Vaginal Anti Infectives Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Vaginal Anti Infectives Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Vaginal Anti Infectives Production Comparison
4.2.1 United States VS China: Vaginal Anti Infectives Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Vaginal Anti Infectives Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Vaginal Anti Infectives Consumption Comparison
4.3.1 United States VS China: Vaginal Anti Infectives Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Vaginal Anti Infectives Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Vaginal Anti Infectives Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Vaginal Anti Infectives in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Vaginal Anti Infectives Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Vaginal Anti Infectives Production by Domestic Manufacturer, (2017-2022)
4.5 China Vaginal Anti Infectives Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Vaginal Anti Infectives in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Vaginal Anti Infectives Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Vaginal Anti Infectives Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Vaginal Anti Infectives Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Vaginal Anti Infectives in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Vaginal Anti Infectives Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Vaginal Anti Infectives Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Vaginal Anti Infectives Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Ointment
5.3 Market Segment by Type
5.3.1 World Vaginal Anti Infectives Production by Type (2017-2028)
5.3.2 World Vaginal Anti Infectives Production Value by Type (2017-2028)
5.3.3 World Vaginal Anti Infectives Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Vaginal Anti Infectives Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Bacterial Vaginitis
6.2.2 Trichomonal Vaginitis
6.2.3 Candida Vaginitis
6.3 Market Segment by Application
6.3.1 World Vaginal Anti Infectives Production by Application (2017-2028)
6.3.2 World Vaginal Anti Infectives Production Value by Application (2017-2028)
6.3.3 World Vaginal Anti Infectives Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Pfizer Inc
7.1.1 Pfizer Inc Details
7.1.2 Pfizer Inc Major Business
7.1.3 Pfizer Inc Vaginal Anti Infectives Product and Services
7.1.4 Pfizer Inc Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Pfizer Inc Recent Developments/Updates
7.1.6 Pfizer Inc Competitive Strengths & Weaknesses
7.2 Mylan N.V
7.2.1 Mylan N.V Details
7.2.2 Mylan N.V Major Business
7.2.3 Mylan N.V Vaginal Anti Infectives Product and Services
7.2.4 Mylan N.V Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Mylan N.V Recent Developments/Updates
7.2.6 Mylan N.V Competitive Strengths & Weaknesses
7.3 Novartis AG
7.3.1 Novartis AG Details
7.3.2 Novartis AG Major Business
7.3.3 Novartis AG Vaginal Anti Infectives Product and Services
7.3.4 Novartis AG Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Novartis AG Recent Developments/Updates
7.3.6 Novartis AG Competitive Strengths & Weaknesses
7.4 Hikma Pharmaceuticals plc
7.4.1 Hikma Pharmaceuticals plc Details
7.4.2 Hikma Pharmaceuticals plc Major Business
7.4.3 Hikma Pharmaceuticals plc Vaginal Anti Infectives Product and Services
7.4.4 Hikma Pharmaceuticals plc Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Hikma Pharmaceuticals plc Recent Developments/Updates
7.4.6 Hikma Pharmaceuticals plc Competitive Strengths & Weaknesses
7.5 Aurobindo Pharma
7.5.1 Aurobindo Pharma Details
7.5.2 Aurobindo Pharma Major Business
7.5.3 Aurobindo Pharma Vaginal Anti Infectives Product and Services
7.5.4 Aurobindo Pharma Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Aurobindo Pharma Recent Developments/Updates
7.5.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.6 AbbVie Inc
7.6.1 AbbVie Inc Details
7.6.2 AbbVie Inc Major Business
7.6.3 AbbVie Inc Vaginal Anti Infectives Product and Services
7.6.4 AbbVie Inc Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 AbbVie Inc Recent Developments/Updates
7.6.6 AbbVie Inc Competitive Strengths & Weaknesses
7.7 Melinta Therapeutics, Inc
7.7.1 Melinta Therapeutics, Inc Details
7.7.2 Melinta Therapeutics, Inc Major Business
7.7.3 Melinta Therapeutics, Inc Vaginal Anti Infectives Product and Services
7.7.4 Melinta Therapeutics, Inc Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Melinta Therapeutics, Inc Recent Developments/Updates
7.7.6 Melinta Therapeutics, Inc Competitive Strengths & Weaknesses
7.8 Bristol-Myers Squibb Company
7.8.1 Bristol-Myers Squibb Company Details
7.8.2 Bristol-Myers Squibb Company Major Business
7.8.3 Bristol-Myers Squibb Company Vaginal Anti Infectives Product and Services
7.8.4 Bristol-Myers Squibb Company Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Bristol-Myers Squibb Company Recent Developments/Updates
7.8.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
7.9 GSK plc
7.9.1 GSK plc Details
7.9.2 GSK plc Major Business
7.9.3 GSK plc Vaginal Anti Infectives Product and Services
7.9.4 GSK plc Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 GSK plc Recent Developments/Updates
7.9.6 GSK plc Competitive Strengths & Weaknesses
7.10 Bayer AG
7.10.1 Bayer AG Details
7.10.2 Bayer AG Major Business
7.10.3 Bayer AG Vaginal Anti Infectives Product and Services
7.10.4 Bayer AG Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Bayer AG Recent Developments/Updates
7.10.6 Bayer AG Competitive Strengths & Weaknesses
7.11 Lupin
7.11.1 Lupin Details
7.11.2 Lupin Major Business
7.11.3 Lupin Vaginal Anti Infectives Product and Services
7.11.4 Lupin Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Lupin Recent Developments/Updates
7.11.6 Lupin Competitive Strengths & Weaknesses
7.12 Perrigo Company plc
7.12.1 Perrigo Company plc Details
7.12.2 Perrigo Company plc Major Business
7.12.3 Perrigo Company plc Vaginal Anti Infectives Product and Services
7.12.4 Perrigo Company plc Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Perrigo Company plc Recent Developments/Updates
7.12.6 Perrigo Company plc Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Vaginal Anti Infectives and Key Manufacturers
8.2 Vaginal Anti Infectives Manufacturing Costs
8.3 Vaginal Anti Infectives Production Process
8.4 Vaginal Anti Infectives Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Vaginal Anti Infectives Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Vaginal Anti Infectives Typical Distributors
9.3 Vaginal Anti Infectives Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Vaginal Anti Infectives Introduction
1.2 World Vaginal Anti Infectives Supply & Forecast
1.2.1 World Vaginal Anti Infectives Production Value (2017 & 2021 & 2028)
1.2.2 World Vaginal Anti Infectives Production (2017-2028)
1.2.3 World Vaginal Anti Infectives Pricing Trends (2017-2028)
1.3 World Vaginal Anti Infectives Production by Region
1.3.1 World Vaginal Anti Infectives Production Value by Region (2017-2028)
1.3.2 World Vaginal Anti Infectives Production by Region (2017-2028)
1.3.3 World Vaginal Anti Infectives Average Price by Region (2017-2028)
1.3.4 North America Vaginal Anti Infectives Production (2017-2028)
1.3.5 Europe Vaginal Anti Infectives Production (2017-2028)
1.3.6 China Vaginal Anti Infectives Production (2017-2028)
1.3.7 Japan Vaginal Anti Infectives Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Vaginal Anti Infectives Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Vaginal Anti Infectives Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Vaginal Anti Infectives Demand (2017-2028)
2.2 World Vaginal Anti Infectives Consumption by Region
2.2.1 World Vaginal Anti Infectives Consumption by Region (2017-2022)
2.2.2 World Vaginal Anti Infectives Consumption Forecast by Region (2023-2028)
2.3 United States Vaginal Anti Infectives Consumption (2017-2028)
2.4 China Vaginal Anti Infectives Consumption (2017-2028)
2.5 Europe Vaginal Anti Infectives Consumption (2017-2028)
2.6 Japan Vaginal Anti Infectives Consumption (2017-2028)
2.7 South Korea Vaginal Anti Infectives Consumption (2017-2028)
2.8 ASEAN Vaginal Anti Infectives Consumption (2017-2028)
2.9 India Vaginal Anti Infectives Consumption (2017-2028)
3 WORLD VAGINAL ANTI INFECTIVES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Vaginal Anti Infectives Production Value by Manufacturer (2017-2022)
3.2 World Vaginal Anti Infectives Production by Manufacturer (2017-2022)
3.3 World Vaginal Anti Infectives Average Price by Manufacturer (2017-2022)
3.4 Vaginal Anti Infectives Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Vaginal Anti Infectives Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Vaginal Anti Infectives in 2021
3.5.3 Global Concentration Ratios (CR8) for Vaginal Anti Infectives in 2021
3.6 Vaginal Anti Infectives Market: Overall Company Footprint Analysis
3.6.1 Vaginal Anti Infectives Market: Region Footprint
3.6.2 Vaginal Anti Infectives Market: Company Product Type Footprint
3.6.3 Vaginal Anti Infectives Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Vaginal Anti Infectives Production Value Comparison
4.1.1 United States VS China: Vaginal Anti Infectives Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Vaginal Anti Infectives Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Vaginal Anti Infectives Production Comparison
4.2.1 United States VS China: Vaginal Anti Infectives Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Vaginal Anti Infectives Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Vaginal Anti Infectives Consumption Comparison
4.3.1 United States VS China: Vaginal Anti Infectives Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Vaginal Anti Infectives Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Vaginal Anti Infectives Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Vaginal Anti Infectives in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Vaginal Anti Infectives Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Vaginal Anti Infectives Production by Domestic Manufacturer, (2017-2022)
4.5 China Vaginal Anti Infectives Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Vaginal Anti Infectives in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Vaginal Anti Infectives Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Vaginal Anti Infectives Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Vaginal Anti Infectives Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Vaginal Anti Infectives in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Vaginal Anti Infectives Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Vaginal Anti Infectives Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Vaginal Anti Infectives Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Ointment
5.3 Market Segment by Type
5.3.1 World Vaginal Anti Infectives Production by Type (2017-2028)
5.3.2 World Vaginal Anti Infectives Production Value by Type (2017-2028)
5.3.3 World Vaginal Anti Infectives Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Vaginal Anti Infectives Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Bacterial Vaginitis
6.2.2 Trichomonal Vaginitis
6.2.3 Candida Vaginitis
6.3 Market Segment by Application
6.3.1 World Vaginal Anti Infectives Production by Application (2017-2028)
6.3.2 World Vaginal Anti Infectives Production Value by Application (2017-2028)
6.3.3 World Vaginal Anti Infectives Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Pfizer Inc
7.1.1 Pfizer Inc Details
7.1.2 Pfizer Inc Major Business
7.1.3 Pfizer Inc Vaginal Anti Infectives Product and Services
7.1.4 Pfizer Inc Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Pfizer Inc Recent Developments/Updates
7.1.6 Pfizer Inc Competitive Strengths & Weaknesses
7.2 Mylan N.V
7.2.1 Mylan N.V Details
7.2.2 Mylan N.V Major Business
7.2.3 Mylan N.V Vaginal Anti Infectives Product and Services
7.2.4 Mylan N.V Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Mylan N.V Recent Developments/Updates
7.2.6 Mylan N.V Competitive Strengths & Weaknesses
7.3 Novartis AG
7.3.1 Novartis AG Details
7.3.2 Novartis AG Major Business
7.3.3 Novartis AG Vaginal Anti Infectives Product and Services
7.3.4 Novartis AG Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Novartis AG Recent Developments/Updates
7.3.6 Novartis AG Competitive Strengths & Weaknesses
7.4 Hikma Pharmaceuticals plc
7.4.1 Hikma Pharmaceuticals plc Details
7.4.2 Hikma Pharmaceuticals plc Major Business
7.4.3 Hikma Pharmaceuticals plc Vaginal Anti Infectives Product and Services
7.4.4 Hikma Pharmaceuticals plc Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Hikma Pharmaceuticals plc Recent Developments/Updates
7.4.6 Hikma Pharmaceuticals plc Competitive Strengths & Weaknesses
7.5 Aurobindo Pharma
7.5.1 Aurobindo Pharma Details
7.5.2 Aurobindo Pharma Major Business
7.5.3 Aurobindo Pharma Vaginal Anti Infectives Product and Services
7.5.4 Aurobindo Pharma Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Aurobindo Pharma Recent Developments/Updates
7.5.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.6 AbbVie Inc
7.6.1 AbbVie Inc Details
7.6.2 AbbVie Inc Major Business
7.6.3 AbbVie Inc Vaginal Anti Infectives Product and Services
7.6.4 AbbVie Inc Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 AbbVie Inc Recent Developments/Updates
7.6.6 AbbVie Inc Competitive Strengths & Weaknesses
7.7 Melinta Therapeutics, Inc
7.7.1 Melinta Therapeutics, Inc Details
7.7.2 Melinta Therapeutics, Inc Major Business
7.7.3 Melinta Therapeutics, Inc Vaginal Anti Infectives Product and Services
7.7.4 Melinta Therapeutics, Inc Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Melinta Therapeutics, Inc Recent Developments/Updates
7.7.6 Melinta Therapeutics, Inc Competitive Strengths & Weaknesses
7.8 Bristol-Myers Squibb Company
7.8.1 Bristol-Myers Squibb Company Details
7.8.2 Bristol-Myers Squibb Company Major Business
7.8.3 Bristol-Myers Squibb Company Vaginal Anti Infectives Product and Services
7.8.4 Bristol-Myers Squibb Company Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Bristol-Myers Squibb Company Recent Developments/Updates
7.8.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
7.9 GSK plc
7.9.1 GSK plc Details
7.9.2 GSK plc Major Business
7.9.3 GSK plc Vaginal Anti Infectives Product and Services
7.9.4 GSK plc Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 GSK plc Recent Developments/Updates
7.9.6 GSK plc Competitive Strengths & Weaknesses
7.10 Bayer AG
7.10.1 Bayer AG Details
7.10.2 Bayer AG Major Business
7.10.3 Bayer AG Vaginal Anti Infectives Product and Services
7.10.4 Bayer AG Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Bayer AG Recent Developments/Updates
7.10.6 Bayer AG Competitive Strengths & Weaknesses
7.11 Lupin
7.11.1 Lupin Details
7.11.2 Lupin Major Business
7.11.3 Lupin Vaginal Anti Infectives Product and Services
7.11.4 Lupin Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Lupin Recent Developments/Updates
7.11.6 Lupin Competitive Strengths & Weaknesses
7.12 Perrigo Company plc
7.12.1 Perrigo Company plc Details
7.12.2 Perrigo Company plc Major Business
7.12.3 Perrigo Company plc Vaginal Anti Infectives Product and Services
7.12.4 Perrigo Company plc Vaginal Anti Infectives Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Perrigo Company plc Recent Developments/Updates
7.12.6 Perrigo Company plc Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Vaginal Anti Infectives and Key Manufacturers
8.2 Vaginal Anti Infectives Manufacturing Costs
8.3 Vaginal Anti Infectives Production Process
8.4 Vaginal Anti Infectives Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Vaginal Anti Infectives Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Vaginal Anti Infectives Typical Distributors
9.3 Vaginal Anti Infectives Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Vaginal Anti Infectives Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Vaginal Anti Infectives Production Value by Region (2017-2022) & (USD Million)
Table 3. World Vaginal Anti Infectives Production Value by Region (2023-2028) & (USD Million)
Table 4. World Vaginal Anti Infectives Production Value Market Share by Region (2017-2022)
Table 5. World Vaginal Anti Infectives Production Value Market Share by Region (2023-2028)
Table 6. World Vaginal Anti Infectives Production by Region (2017-2022) & (K Units)
Table 7. World Vaginal Anti Infectives Production by Region (2023-2028) & (K Units)
Table 8. World Vaginal Anti Infectives Production Market Share by Region (2017-2022)
Table 9. World Vaginal Anti Infectives Production Market Share by Region (2023-2028)
Table 10. World Vaginal Anti Infectives Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Vaginal Anti Infectives Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Vaginal Anti Infectives Major Market Trends
Table 13. World Vaginal Anti Infectives Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Vaginal Anti Infectives Consumption by Region (2017-2022) & (K Units)
Table 15. World Vaginal Anti Infectives Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Vaginal Anti Infectives Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Vaginal Anti Infectives Producers in 2021
Table 18. World Vaginal Anti Infectives Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Vaginal Anti Infectives Producers in 2021
Table 20. World Vaginal Anti Infectives Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Vaginal Anti Infectives Company Evaluation Quadrant
Table 22. World Vaginal Anti Infectives Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Vaginal Anti Infectives Production Site of Key Manufacturer
Table 24. Vaginal Anti Infectives Market: Company Product Type Footprint
Table 25. Vaginal Anti Infectives Market: Company Product Application Footprint
Table 26. Vaginal Anti Infectives Competitive Factors
Table 27. Vaginal Anti Infectives New Entrant and Capacity Expansion Plans
Table 28. Vaginal Anti Infectives Mergers & Acquisitions Activity
Table 29. United States VS China Vaginal Anti Infectives Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Vaginal Anti Infectives Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Vaginal Anti Infectives Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Vaginal Anti Infectives in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Vaginal Anti Infectives Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Vaginal Anti Infectives Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Vaginal Anti Infectives Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Vaginal Anti Infectives Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Vaginal Anti Infectives in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Vaginal Anti Infectives Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Vaginal Anti Infectives Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Vaginal Anti Infectives Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Vaginal Anti Infectives Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Vaginal Anti Infectives in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Vaginal Anti Infectives Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Vaginal Anti Infectives Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Vaginal Anti Infectives Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Vaginal Anti Infectives Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Vaginal Anti Infectives Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Vaginal Anti Infectives Production by Type (2017-2022) & (K Units)
Table 49. World Vaginal Anti Infectives Production by Type (2023-2028) & (K Units)
Table 50. World Vaginal Anti Infectives Production Value by Type (2017-2022) & (USD Million)
Table 51. World Vaginal Anti Infectives Production Value by Type (2023-2028) & (USD Million)
Table 52. World Vaginal Anti Infectives Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Vaginal Anti Infectives Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Vaginal Anti Infectives Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Vaginal Anti Infectives Production by Application (2017-2022) & (K Units)
Table 56. World Vaginal Anti Infectives Production by Application (2023-2028) & (K Units)
Table 57. World Vaginal Anti Infectives Production Value by Application (2017-2022) & (USD Million)
Table 58. World Vaginal Anti Infectives Production Value by Application (2023-2028) & (USD Million)
Table 59. World Vaginal Anti Infectives Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Vaginal Anti Infectives Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Inc Major Business
Table 63. Pfizer Inc Vaginal Anti Infectives Product and Services
Table 64. Pfizer Inc Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Pfizer Inc Recent Developments/Updates
Table 66. Pfizer Inc Competitive Strengths & Weaknesses
Table 67. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 68. Mylan N.V Major Business
Table 69. Mylan N.V Vaginal Anti Infectives Product and Services
Table 70. Mylan N.V Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Mylan N.V Recent Developments/Updates
Table 72. Mylan N.V Competitive Strengths & Weaknesses
Table 73. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 74. Novartis AG Major Business
Table 75. Novartis AG Vaginal Anti Infectives Product and Services
Table 76. Novartis AG Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Novartis AG Recent Developments/Updates
Table 78. Novartis AG Competitive Strengths & Weaknesses
Table 79. Hikma Pharmaceuticals plc Basic Information, Manufacturing Base and Competitors
Table 80. Hikma Pharmaceuticals plc Major Business
Table 81. Hikma Pharmaceuticals plc Vaginal Anti Infectives Product and Services
Table 82. Hikma Pharmaceuticals plc Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Hikma Pharmaceuticals plc Recent Developments/Updates
Table 84. Hikma Pharmaceuticals plc Competitive Strengths & Weaknesses
Table 85. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Aurobindo Pharma Major Business
Table 87. Aurobindo Pharma Vaginal Anti Infectives Product and Services
Table 88. Aurobindo Pharma Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Aurobindo Pharma Recent Developments/Updates
Table 90. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 91. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 92. AbbVie Inc Major Business
Table 93. AbbVie Inc Vaginal Anti Infectives Product and Services
Table 94. AbbVie Inc Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. AbbVie Inc Recent Developments/Updates
Table 96. AbbVie Inc Competitive Strengths & Weaknesses
Table 97. Melinta Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 98. Melinta Therapeutics, Inc Major Business
Table 99. Melinta Therapeutics, Inc Vaginal Anti Infectives Product and Services
Table 100. Melinta Therapeutics, Inc Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Melinta Therapeutics, Inc Recent Developments/Updates
Table 102. Melinta Therapeutics, Inc Competitive Strengths & Weaknesses
Table 103. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 104. Bristol-Myers Squibb Company Major Business
Table 105. Bristol-Myers Squibb Company Vaginal Anti Infectives Product and Services
Table 106. Bristol-Myers Squibb Company Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Bristol-Myers Squibb Company Recent Developments/Updates
Table 108. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
Table 109. GSK plc Basic Information, Manufacturing Base and Competitors
Table 110. GSK plc Major Business
Table 111. GSK plc Vaginal Anti Infectives Product and Services
Table 112. GSK plc Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. GSK plc Recent Developments/Updates
Table 114. GSK plc Competitive Strengths & Weaknesses
Table 115. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 116. Bayer AG Major Business
Table 117. Bayer AG Vaginal Anti Infectives Product and Services
Table 118. Bayer AG Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Bayer AG Recent Developments/Updates
Table 120. Bayer AG Competitive Strengths & Weaknesses
Table 121. Lupin Basic Information, Manufacturing Base and Competitors
Table 122. Lupin Major Business
Table 123. Lupin Vaginal Anti Infectives Product and Services
Table 124. Lupin Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Lupin Recent Developments/Updates
Table 126. Perrigo Company plc Basic Information, Manufacturing Base and Competitors
Table 127. Perrigo Company plc Major Business
Table 128. Perrigo Company plc Vaginal Anti Infectives Product and Services
Table 129. Perrigo Company plc Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. Vaginal Anti Infectives Raw Material
Table 131. Key Manufacturers of Vaginal Anti Infectives Raw Materials
Table 132. Vaginal Anti Infectives Typical Distributors
Table 133. Vaginal Anti Infectives Typical Customers
Table 1. World Vaginal Anti Infectives Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Vaginal Anti Infectives Production Value by Region (2017-2022) & (USD Million)
Table 3. World Vaginal Anti Infectives Production Value by Region (2023-2028) & (USD Million)
Table 4. World Vaginal Anti Infectives Production Value Market Share by Region (2017-2022)
Table 5. World Vaginal Anti Infectives Production Value Market Share by Region (2023-2028)
Table 6. World Vaginal Anti Infectives Production by Region (2017-2022) & (K Units)
Table 7. World Vaginal Anti Infectives Production by Region (2023-2028) & (K Units)
Table 8. World Vaginal Anti Infectives Production Market Share by Region (2017-2022)
Table 9. World Vaginal Anti Infectives Production Market Share by Region (2023-2028)
Table 10. World Vaginal Anti Infectives Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Vaginal Anti Infectives Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Vaginal Anti Infectives Major Market Trends
Table 13. World Vaginal Anti Infectives Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Vaginal Anti Infectives Consumption by Region (2017-2022) & (K Units)
Table 15. World Vaginal Anti Infectives Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Vaginal Anti Infectives Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Vaginal Anti Infectives Producers in 2021
Table 18. World Vaginal Anti Infectives Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Vaginal Anti Infectives Producers in 2021
Table 20. World Vaginal Anti Infectives Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Vaginal Anti Infectives Company Evaluation Quadrant
Table 22. World Vaginal Anti Infectives Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Vaginal Anti Infectives Production Site of Key Manufacturer
Table 24. Vaginal Anti Infectives Market: Company Product Type Footprint
Table 25. Vaginal Anti Infectives Market: Company Product Application Footprint
Table 26. Vaginal Anti Infectives Competitive Factors
Table 27. Vaginal Anti Infectives New Entrant and Capacity Expansion Plans
Table 28. Vaginal Anti Infectives Mergers & Acquisitions Activity
Table 29. United States VS China Vaginal Anti Infectives Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Vaginal Anti Infectives Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Vaginal Anti Infectives Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Vaginal Anti Infectives in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Vaginal Anti Infectives Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Vaginal Anti Infectives Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Vaginal Anti Infectives Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Vaginal Anti Infectives Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Vaginal Anti Infectives in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Vaginal Anti Infectives Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Vaginal Anti Infectives Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Vaginal Anti Infectives Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Vaginal Anti Infectives Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Vaginal Anti Infectives in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Vaginal Anti Infectives Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Vaginal Anti Infectives Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Vaginal Anti Infectives Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Vaginal Anti Infectives Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Vaginal Anti Infectives Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Vaginal Anti Infectives Production by Type (2017-2022) & (K Units)
Table 49. World Vaginal Anti Infectives Production by Type (2023-2028) & (K Units)
Table 50. World Vaginal Anti Infectives Production Value by Type (2017-2022) & (USD Million)
Table 51. World Vaginal Anti Infectives Production Value by Type (2023-2028) & (USD Million)
Table 52. World Vaginal Anti Infectives Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Vaginal Anti Infectives Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Vaginal Anti Infectives Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Vaginal Anti Infectives Production by Application (2017-2022) & (K Units)
Table 56. World Vaginal Anti Infectives Production by Application (2023-2028) & (K Units)
Table 57. World Vaginal Anti Infectives Production Value by Application (2017-2022) & (USD Million)
Table 58. World Vaginal Anti Infectives Production Value by Application (2023-2028) & (USD Million)
Table 59. World Vaginal Anti Infectives Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Vaginal Anti Infectives Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Inc Major Business
Table 63. Pfizer Inc Vaginal Anti Infectives Product and Services
Table 64. Pfizer Inc Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Pfizer Inc Recent Developments/Updates
Table 66. Pfizer Inc Competitive Strengths & Weaknesses
Table 67. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 68. Mylan N.V Major Business
Table 69. Mylan N.V Vaginal Anti Infectives Product and Services
Table 70. Mylan N.V Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Mylan N.V Recent Developments/Updates
Table 72. Mylan N.V Competitive Strengths & Weaknesses
Table 73. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 74. Novartis AG Major Business
Table 75. Novartis AG Vaginal Anti Infectives Product and Services
Table 76. Novartis AG Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Novartis AG Recent Developments/Updates
Table 78. Novartis AG Competitive Strengths & Weaknesses
Table 79. Hikma Pharmaceuticals plc Basic Information, Manufacturing Base and Competitors
Table 80. Hikma Pharmaceuticals plc Major Business
Table 81. Hikma Pharmaceuticals plc Vaginal Anti Infectives Product and Services
Table 82. Hikma Pharmaceuticals plc Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Hikma Pharmaceuticals plc Recent Developments/Updates
Table 84. Hikma Pharmaceuticals plc Competitive Strengths & Weaknesses
Table 85. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 86. Aurobindo Pharma Major Business
Table 87. Aurobindo Pharma Vaginal Anti Infectives Product and Services
Table 88. Aurobindo Pharma Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Aurobindo Pharma Recent Developments/Updates
Table 90. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 91. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 92. AbbVie Inc Major Business
Table 93. AbbVie Inc Vaginal Anti Infectives Product and Services
Table 94. AbbVie Inc Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. AbbVie Inc Recent Developments/Updates
Table 96. AbbVie Inc Competitive Strengths & Weaknesses
Table 97. Melinta Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 98. Melinta Therapeutics, Inc Major Business
Table 99. Melinta Therapeutics, Inc Vaginal Anti Infectives Product and Services
Table 100. Melinta Therapeutics, Inc Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Melinta Therapeutics, Inc Recent Developments/Updates
Table 102. Melinta Therapeutics, Inc Competitive Strengths & Weaknesses
Table 103. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 104. Bristol-Myers Squibb Company Major Business
Table 105. Bristol-Myers Squibb Company Vaginal Anti Infectives Product and Services
Table 106. Bristol-Myers Squibb Company Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Bristol-Myers Squibb Company Recent Developments/Updates
Table 108. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
Table 109. GSK plc Basic Information, Manufacturing Base and Competitors
Table 110. GSK plc Major Business
Table 111. GSK plc Vaginal Anti Infectives Product and Services
Table 112. GSK plc Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. GSK plc Recent Developments/Updates
Table 114. GSK plc Competitive Strengths & Weaknesses
Table 115. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 116. Bayer AG Major Business
Table 117. Bayer AG Vaginal Anti Infectives Product and Services
Table 118. Bayer AG Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Bayer AG Recent Developments/Updates
Table 120. Bayer AG Competitive Strengths & Weaknesses
Table 121. Lupin Basic Information, Manufacturing Base and Competitors
Table 122. Lupin Major Business
Table 123. Lupin Vaginal Anti Infectives Product and Services
Table 124. Lupin Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Lupin Recent Developments/Updates
Table 126. Perrigo Company plc Basic Information, Manufacturing Base and Competitors
Table 127. Perrigo Company plc Major Business
Table 128. Perrigo Company plc Vaginal Anti Infectives Product and Services
Table 129. Perrigo Company plc Vaginal Anti Infectives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. Vaginal Anti Infectives Raw Material
Table 131. Key Manufacturers of Vaginal Anti Infectives Raw Materials
Table 132. Vaginal Anti Infectives Typical Distributors
Table 133. Vaginal Anti Infectives Typical Customers
LIST OF FIGURES
Figure 1. Vaginal Anti Infectives Picture
Figure 2. World Vaginal Anti Infectives Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Vaginal Anti Infectives Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Vaginal Anti Infectives Production (2017-2028) & (K Units)
Figure 5. World Vaginal Anti Infectives Average Price (2017-2028) & (US$/Unit)
Figure 6. World Vaginal Anti Infectives Production Value Market Share by Region (2017-2028)
Figure 7. World Vaginal Anti Infectives Production Market Share by Region (2017-2028)
Figure 8. North America Vaginal Anti Infectives Production (2017-2028) & (K Units)
Figure 9. Europe Vaginal Anti Infectives Production (2017-2028) & (K Units)
Figure 10. China Vaginal Anti Infectives Production (2017-2028) & (K Units)
Figure 11. Japan Vaginal Anti Infectives Production (2017-2028) & (K Units)
Figure 12. Vaginal Anti Infectives Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Vaginal Anti Infectives Demand (2017-2028) & (K Units)
Figure 15. World Vaginal Anti Infectives Consumption Market Share by Region (2017-2028)
Figure 16. United States Vaginal Anti Infectives Consumption (2017-2028) & (K Units)
Figure 17. China Vaginal Anti Infectives Consumption (2017-2028) & (K Units)
Figure 18. Europe Vaginal Anti Infectives Consumption (2017-2028) & (K Units)
Figure 19. Japan Vaginal Anti Infectives Consumption (2017-2028) & (K Units)
Figure 20. South Korea Vaginal Anti Infectives Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Vaginal Anti Infectives Consumption (2017-2028) & (K Units)
Figure 22. India Vaginal Anti Infectives Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Vaginal Anti Infectives by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Vaginal Anti Infectives Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Vaginal Anti Infectives Markets in 2021
Figure 26. United States VS China: Vaginal Anti Infectives Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Vaginal Anti Infectives Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Vaginal Anti Infectives Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Vaginal Anti Infectives in United States
Figure 30. Key Producers and Market Share of Vaginal Anti Infectives in China
Figure 31. Key Producers and Market Share of Vaginal Anti Infectives in Rest of World
Figure 32. World Vaginal Anti Infectives Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Vaginal Anti Infectives Production Value Market Share by Type in 2021
Figure 34. Oral
Figure 35. Ointment
Figure 36. World Vaginal Anti Infectives Production Market Share by Type (2017-2028)
Figure 37. World Vaginal Anti Infectives Production Value Market Share by Type (2017-2028)
Figure 38. World Vaginal Anti Infectives Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Vaginal Anti Infectives Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Vaginal Anti Infectives Production Value Market Share by Application in 2021
Figure 41. Bacterial Vaginitis
Figure 42. Trichomonal Vaginitis
Figure 43. Candida Vaginitis
Figure 44. World Vaginal Anti Infectives Production Market Share by Application (2017-2028)
Figure 45. World Vaginal Anti Infectives Production Value Market Share by Application (2017-2028)
Figure 46. World Vaginal Anti Infectives Average Price by Application (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of Vaginal Anti Infectives in 2021
Figure 48. Manufacturing Process Analysis of Vaginal Anti Infectives
Figure 49. Vaginal Anti Infectives Industrial Chain
Figure 50. Distribution Channel Breakdown for Vaginal Anti Infectives Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Vaginal Anti Infectives Picture
Figure 2. World Vaginal Anti Infectives Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Vaginal Anti Infectives Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Vaginal Anti Infectives Production (2017-2028) & (K Units)
Figure 5. World Vaginal Anti Infectives Average Price (2017-2028) & (US$/Unit)
Figure 6. World Vaginal Anti Infectives Production Value Market Share by Region (2017-2028)
Figure 7. World Vaginal Anti Infectives Production Market Share by Region (2017-2028)
Figure 8. North America Vaginal Anti Infectives Production (2017-2028) & (K Units)
Figure 9. Europe Vaginal Anti Infectives Production (2017-2028) & (K Units)
Figure 10. China Vaginal Anti Infectives Production (2017-2028) & (K Units)
Figure 11. Japan Vaginal Anti Infectives Production (2017-2028) & (K Units)
Figure 12. Vaginal Anti Infectives Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Vaginal Anti Infectives Demand (2017-2028) & (K Units)
Figure 15. World Vaginal Anti Infectives Consumption Market Share by Region (2017-2028)
Figure 16. United States Vaginal Anti Infectives Consumption (2017-2028) & (K Units)
Figure 17. China Vaginal Anti Infectives Consumption (2017-2028) & (K Units)
Figure 18. Europe Vaginal Anti Infectives Consumption (2017-2028) & (K Units)
Figure 19. Japan Vaginal Anti Infectives Consumption (2017-2028) & (K Units)
Figure 20. South Korea Vaginal Anti Infectives Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Vaginal Anti Infectives Consumption (2017-2028) & (K Units)
Figure 22. India Vaginal Anti Infectives Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Vaginal Anti Infectives by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Vaginal Anti Infectives Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Vaginal Anti Infectives Markets in 2021
Figure 26. United States VS China: Vaginal Anti Infectives Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Vaginal Anti Infectives Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Vaginal Anti Infectives Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Vaginal Anti Infectives in United States
Figure 30. Key Producers and Market Share of Vaginal Anti Infectives in China
Figure 31. Key Producers and Market Share of Vaginal Anti Infectives in Rest of World
Figure 32. World Vaginal Anti Infectives Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Vaginal Anti Infectives Production Value Market Share by Type in 2021
Figure 34. Oral
Figure 35. Ointment
Figure 36. World Vaginal Anti Infectives Production Market Share by Type (2017-2028)
Figure 37. World Vaginal Anti Infectives Production Value Market Share by Type (2017-2028)
Figure 38. World Vaginal Anti Infectives Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Vaginal Anti Infectives Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Vaginal Anti Infectives Production Value Market Share by Application in 2021
Figure 41. Bacterial Vaginitis
Figure 42. Trichomonal Vaginitis
Figure 43. Candida Vaginitis
Figure 44. World Vaginal Anti Infectives Production Market Share by Application (2017-2028)
Figure 45. World Vaginal Anti Infectives Production Value Market Share by Application (2017-2028)
Figure 46. World Vaginal Anti Infectives Average Price by Application (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of Vaginal Anti Infectives in 2021
Figure 48. Manufacturing Process Analysis of Vaginal Anti Infectives
Figure 49. Vaginal Anti Infectives Industrial Chain
Figure 50. Distribution Channel Breakdown for Vaginal Anti Infectives Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
